Deepak Soneji, MD is a research investigator with REDI.
Sutter Health Research Enterprise
2850 Telegraph Ave, Suite 110
Berkeley, CA, 94705
(510) 204-8140
Deepak.soneji@sutterhealth.org
Primary Research Interests
Related Clinical Trials
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Ex
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Rela
Investigators: Matthew W. Arnold M.D., Joanna A. Cooper M.D., Lynn Jehle NP, Deepak Soneji MD, Bradley T Wrubel MD
Status: Active, Recruiting
Ketamine for MS Fatigue
Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS)
Investigators: Joanna A. Cooper M.D., Deepak Soneji MD
Status: Active, Recruiting